Funding for this research was provided by:
National Heart, Lung, and Blood Institute (5U24NS100651)
National Institutes of Health (R01AG047975, R01AG026484, P50AG005134, K23AG02872605)
National Institute of Neurological Disorders and Stroke (R01NS103924)
American Heart Association (18SFRN34250007)
Massachusetts General Hospital
Agency for Healthcare Research and Quality (K08 HS024561)
Received: 13 September 2020
Accepted: 5 January 2021
First Online: 19 January 2021
Ethics approval and consent to participate
: Ethical approval was obtained from the Partners Institutional Review Board for the use of the patient data in this retrospective chart review study.
: Not applicable
: The authors declare no disclosures other than the following:JNG: Research funding from NIH, Pfizer, Octapharma, and consulting from Portola, Phillips, NControl, and Takeda.CA: Sponsored research support from Bayer AG, and consulting fees for ApoPharma, Inc.The authors declare that they have no competing interests.